During the past decade, JSC Infectious Diseases, AIDS and Clinical Immunology Research Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center" #1 sponsor was "Celgene" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "GB004, Inc." with 1 trials sponsored and "Reistone Biopharma Company Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center" are "Ulcerative Colitis" (6 trials), "Crohn Disease" (3 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center" in a lesser frequency.

Most popular intervention types in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (5 trials), "Ozanimod" (3 trials), "GB004" (1 trials) and "SHR0302" (1 trials). Other intervention names were less common.

The vast majority of trials in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "JSC Infectious Diseases, AIDS and Clinical Immunology Research Center". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".